Literature DB >> 199690

Replication of enterovirus 70 in non-primate cell cultures.

T Yoshii, K Natori, R Kono.   

Abstract

Replication of the strain J 670/71 of enterovirus 70 (EV70) in non-primate cell cultures at 33 degrees C was studied using strain L (mouse), BHK21 (hamster), RK13 (rabbit), RK17 (rabbit), PK15 (porcine), IB-RS-2 (porcine), ESK (porcine), MDBK (bovine), and BK1 (primary bovine) together with that of the LSc, 2ab strain of poliovrus type 1 (PV1) as a control. All the cells tested adsorbed from 54 to 90% of EV70. The replication with complete c.p.e. was evident in RK13, RK17 and BK1 cells; replication without c.p.e. was shown in L, BHK21, IB-RS-2 and ESK; but PK15 and MDBK were non-permissive despite a high virus adsorption rate. On the contrary, none of these non-primate cells allowed the adsorption and growth of PV1. One-step growth of EV70 in RK13 was almost identical with that in the primate cells. Two other strains of EV70 were found having similar host range in vitro. Therefore, it is concluded that EV70 has a wider host range in vitro than ordinary human enteroviruses, and its implication is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199690     DOI: 10.1099/0022-1317-36-3-377

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Detection and genetic characterization of enteroviruses circulating among wild populations of chimpanzees in Cameroon: relationship with human and simian enteroviruses.

Authors:  Heli Harvala; Colin P Sharp; Eitel Mpoudi Ngole; Eric Delaporte; Martine Peeters; Peter Simmonds
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

2.  The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).

Authors:  T M Karnauchow; D L Tolson; B A Harrison; E Altman; D M Lublin; K Dimock
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 3.  Enteroviruses as agents of emerging infectious diseases.

Authors:  G Palacios; M S Oberste
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

4.  Sialic acid functions in enterovirus 70 binding and infection.

Authors:  David A Alexander; Kenneth Dimock
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Evolution of enterovirus 70 in nature: all isolates were recently derived from a common ancestor.

Authors:  K Miyamura; M Tanimura; N Takeda; R Kono; S Yamazaki
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.

Authors:  M Reza Nokhbeh; Samir Hazra; David A Alexander; Ahmar Khan; Morgan McAllister; Erik J Suuronen; May Griffith; Kenneth Dimock
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.

Authors:  Alain Haddad; M Reza Nokhbeh; David A Alexander; Sandra J Dawe; Christine Grisé; Naveed Gulzar; Kenneth Dimock
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.

Authors:  T M Karnauchow; S Dawe; D M Lublin; K Dimock
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains.

Authors:  J C Hierholzer; P G Bingham; R A Coombs; Y O Stone; M H Hatch
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Genetic and phenotypic characterization of recently discovered enterovirus D type 111.

Authors:  Serge Alain Sadeuh-Mba; Marie-Line Joffret; Arthur Mazitchi; Marie-Claire Endegue-Zanga; Richard Njouom; Francis Delpeyroux; Ionela Gouandjika-Vasilache; Maël Bessaud
Journal:  PLoS Negl Trop Dis       Date:  2019-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.